Literature DB >> 3825881

Distribution of propafenone and its active metabolite, 5-hydroxypropafenone, in human tissues.

R Latini, S Marchi, E Riva, A Cavalli, M G Cazzaniga, A P Maggioni, A Volpi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3825881     DOI： 10.1016/0002-8703(87)90735-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

1.  LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats.

Authors:  T C Wascher; P Dittrich; W R Kukovetz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

2.  Tissue distribution of propafenone in the rat after intravenous administration.

Authors:  J Fernández; L Lligoña; A Puigdemont; R Guitart; J L Riu; M Arboix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

3.  [Acute myocardial uptake of lidocaine, mexiletine and amiodarone].

Authors:  J Nitsch; J Leffler; B Lüderitz
Journal:  Klin Wochenschr       Date:  1990-07-05

Review 4.  Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of propafenone.

Authors:  J T Hii; H J Duff; E D Burgess
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

6.  Flecainide distribution in human tissues.

Authors:  R Latini; A Cavalli; A P Maggioni; A Volpi
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.